These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12297612)

  • 41. Clozapine-withdrawal catatonia.
    Wadekar M; Syed S
    Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aripiprazole-induced agitation after clozapine discontinuation: a case report.
    Cho DY; Lindenmayer JP
    J Clin Psychiatry; 2009 Jan; 70(1):141-3. PubMed ID: 19222986
    [No Abstract]   [Full Text] [Related]  

  • 43. What is the clinical significance of the discontinuation syndrome seen with clozapine?
    Goudie AJ
    J Psychopharmacol; 2000 Jun; 14(2):188-92. PubMed ID: 10890315
    [No Abstract]   [Full Text] [Related]  

  • 44. Clozapine withdrawal catatonia or lethal catatonia in a schizoaffective patient with a family history of Parkinson's disease.
    Thanasan S; Jambunathan ST
    Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):402, 404. PubMed ID: 21390412
    [No Abstract]   [Full Text] [Related]  

  • 45. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 46. Clozapine treatment and neuroleptic malignant syndrome.
    Doan RJ; Callaghan WD
    Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
    [No Abstract]   [Full Text] [Related]  

  • 47. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report.
    Rodriguez V; Hanley K; Arias AJ; Quattrone D; Kuforiji J; Whiskey E; Shergill SS
    BMC Pharmacol Toxicol; 2020 May; 21(1):35. PubMed ID: 32434548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.
    Stanilla JK; de Leon J; Simpson GM
    J Clin Psychiatry; 1997 Jun; 58(6):252-5. PubMed ID: 9228890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 52. The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia.
    Baptista T; Beaulieu S
    Acta Psychiatr Scand; 2002 Jun; 105(6):473-4; author reply 474. PubMed ID: 12059854
    [No Abstract]   [Full Text] [Related]  

  • 53. Addictive potential of quetiapine.
    Murphy D; Bailey K; Stone M; Wirshing WC
    Am J Psychiatry; 2008 Jul; 165(7):918. PubMed ID: 18593794
    [No Abstract]   [Full Text] [Related]  

  • 54. Late onset neutropenia with clozapine.
    Panesar N; Pai N; Valachova I
    Aust N Z J Psychiatry; 2011 Aug; 45(8):684. PubMed ID: 21561237
    [No Abstract]   [Full Text] [Related]  

  • 55. Tardive priapism associated with clozapine. A case report.
    Raja M; Azzoni A
    Pharmacopsychiatry; 2006 Sep; 39(5):199-200. PubMed ID: 16944414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine-associated pancreatitis.
    Cerulli TR
    Harv Rev Psychiatry; 1999; 7(1):61-3. PubMed ID: 10439307
    [No Abstract]   [Full Text] [Related]  

  • 57. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
    Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated oculogyric crisis on clozapine discontinuation.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(3):424-5. PubMed ID: 16963596
    [No Abstract]   [Full Text] [Related]  

  • 59. G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis.
    Freeman GM; Martin BA; Hu RJ
    Am J Psychiatry; 2016 Jun; 173(6):643. PubMed ID: 27245191
    [No Abstract]   [Full Text] [Related]  

  • 60. An Unexpected Circumstance: Acute Dystonic Reaction in the Setting of Clozapine Administration.
    Kaplan AM; Pitts WB; Ahmed I
    J Pharm Pract; 2019 Feb; 32(1):103-105. PubMed ID: 29092658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.